ID: ALA3596260

Max Phase: Preclinical

Molecular Formula: C30H49N3O3

Molecular Weight: 499.74

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](CCCn1cc(CCCC(=O)O)nn1)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

Standard InChI:  InChI=1S/C30H49N3O3/c1-20(6-5-17-33-19-22(31-32-33)7-4-8-28(35)36)25-11-12-26-24-10-9-21-18-23(34)13-15-29(21,2)27(24)14-16-30(25,26)3/h19-21,23-27,34H,4-18H2,1-3H3,(H,35,36)/t20-,21-,23-,24+,25-,26+,27+,29+,30-/m1/s1

Standard InChI Key:  BXCGUSKABBJDQP-NSDFNNNCSA-N

Associated Targets(Human)

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 499.74Molecular Weight (Monoisotopic): 499.3774AlogP: 6.12#Rotatable Bonds: 9
Polar Surface Area: 88.24Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.88CX Basic pKa: 0.36CX LogP: 5.85CX LogD: 2.62
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.43Np Likeness Score: 1.06

References

1. Tedaldi L, Wagner GK.  (2014)  Beyond substrate analogues: new inhibitor chemotypes for glycosyltransferases,  (8): [10.1039/C4MD00086B]
2. Singla P, Salunke DB..  (2020)  Recent advances in steroid amino acid conjugates: Old scaffolds with new dimensions.,  187  [PMID:31830636] [10.1016/j.ejmech.2019.111909]

Source